HUP9904073A3 - Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid - Google Patents
Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaidInfo
- Publication number
- HUP9904073A3 HUP9904073A3 HU9904073A HUP9904073A HUP9904073A3 HU P9904073 A3 HUP9904073 A3 HU P9904073A3 HU 9904073 A HU9904073 A HU 9904073A HU P9904073 A HUP9904073 A HU P9904073A HU P9904073 A3 HUP9904073 A3 HU P9904073A3
- Authority
- HU
- Hungary
- Prior art keywords
- nsaid
- compositions
- treatment
- gastrointestinal disorders
- containing bismuth
- Prior art date
Links
- 208000018522 Gastrointestinal disease Diseases 0.000 title 1
- 229910052797 bismuth Inorganic materials 0.000 title 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75551796A | 1996-11-22 | 1996-11-22 | |
| PCT/US1997/021462 WO1998022118A1 (en) | 1996-11-22 | 1997-11-21 | Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9904073A2 HUP9904073A2 (hu) | 2000-03-28 |
| HUP9904073A3 true HUP9904073A3 (en) | 2000-04-28 |
Family
ID=25039481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9904073A HUP9904073A3 (en) | 1996-11-22 | 1997-11-21 | Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0941102A1 (hu) |
| CN (1) | CN1238694A (hu) |
| CA (1) | CA2271381A1 (hu) |
| HU (1) | HUP9904073A3 (hu) |
| NO (1) | NO992468L (hu) |
| TR (1) | TR199901101T2 (hu) |
| WO (1) | WO1998022118A1 (hu) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
| EP1154771A4 (en) * | 1999-02-26 | 2005-04-20 | Nitromed Inc | INHIBITORS OF THE PROTON NITROSIS AND NITROSYL PUMP, COMPOSITIONS AND METHODS OF USE |
| US6852739B1 (en) | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
| TWI289557B (en) | 1999-06-17 | 2007-11-11 | Takeda Chemical Industries Ltd | A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole |
| DK1337525T3 (da) * | 2000-12-01 | 2011-09-19 | Takeda Pharmaceutical | Fremgangsmåde til krystallisering af (R)- eller (S)-lansoprazol |
| US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| US6514960B1 (en) * | 2001-08-27 | 2003-02-04 | Hedonist Biochemical Technologies Co., Ltd. | Use of bismuth subgallate in inhibition of production of nitric oxide synthase |
| WO2004012659A2 (en) | 2002-08-01 | 2004-02-12 | Nitromed, Inc. | Nitrosated proton pump inhibitors, compositions and methods of use |
| EP1552833B1 (en) | 2002-10-16 | 2016-12-28 | Takeda Pharmaceutical Company Limited | Process for producing an amorphous optically active isomer of lansoprazole |
| AU2005264864B2 (en) | 2004-06-16 | 2011-08-11 | Takeda Pharmaceutical Company Limited | Multiple PPI dosage form |
| KR101148399B1 (ko) * | 2005-06-22 | 2012-05-23 | 일양약품주식회사 | 항궤양제 및 점막보호제를 함유하는 경구용 위장질환치료용 약제 조성물 |
| BRPI0909651A2 (pt) | 2008-03-10 | 2015-09-22 | Takeda Pharmaceutical | cristal, agente farmacêutico, método para tratar ou evitar doença, uso do cristal, e, método para a produção de um cristal |
| JP2012502015A (ja) | 2008-09-09 | 2012-01-26 | アストラゼネカ・アクチエボラーグ | 必要がある患者に医薬組成物を送達するための方法 |
| MX2011013467A (es) | 2009-06-25 | 2012-02-13 | Astrazeneca Ab | Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine). |
| MX2014007935A (es) | 2011-12-28 | 2014-11-14 | Pozen Inc | Composiciones y metodos mejorados para el suministro de omeprazol y de acido acetilsalicilico. |
| WO2023143573A1 (zh) * | 2022-01-30 | 2023-08-03 | 上海石趣医药科技有限公司 | 含铋化合物在用于治疗疾病中的用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI910088A (fi) * | 1990-01-09 | 1991-07-10 | Gist Brocades Nv | Oral farmaceutisk komposition. |
| US5128140A (en) * | 1991-01-14 | 1992-07-07 | The Procter & Gamble Company | Swallowable pharmaceutical compositions |
| EP0681476B1 (en) * | 1991-11-22 | 1997-08-27 | The Procter & Gamble Company | Unit dose form of bismuth subsalicylate |
| EP0550083B1 (en) * | 1991-12-06 | 1999-03-24 | Glaxo Group Limited | Medicaments for treating inflammatory conditions or for analgesia containing a NSAID and ranitidine bismuth citrate |
-
1997
- 1997-11-21 CA CA002271381A patent/CA2271381A1/en not_active Abandoned
- 1997-11-21 TR TR1999/01101T patent/TR199901101T2/xx unknown
- 1997-11-21 EP EP97949569A patent/EP0941102A1/en not_active Withdrawn
- 1997-11-21 WO PCT/US1997/021462 patent/WO1998022118A1/en not_active Application Discontinuation
- 1997-11-21 HU HU9904073A patent/HUP9904073A3/hu unknown
- 1997-11-21 CN CN97199982A patent/CN1238694A/zh active Pending
-
1999
- 1999-05-21 NO NO992468A patent/NO992468L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998022118A1 (en) | 1998-05-28 |
| NO992468D0 (no) | 1999-05-21 |
| EP0941102A1 (en) | 1999-09-15 |
| CN1238694A (zh) | 1999-12-15 |
| NO992468L (no) | 1999-07-01 |
| CA2271381A1 (en) | 1998-05-28 |
| HUP9904073A2 (hu) | 2000-03-28 |
| TR199901101T2 (xx) | 1999-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0104676A2 (en) | Compositions for the treatment of anorectal disorders and their use | |
| AU4241596A (en) | Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders | |
| EP0787006A4 (en) | COMPOSITIONS AND METHODS BENEFICIAL TO HUMAN HEALTH IN THE GASTROINTESTINAL APPARATUS | |
| IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
| IL127664A (en) | Compositions for the treatment and prevention of cachexia | |
| HUP9901707A3 (en) | Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders | |
| HUP9904073A3 (en) | Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid | |
| IL135646A0 (en) | α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| IL135366A0 (en) | Substituted benzoxazoles and pharmaceutical compositions containing the same | |
| IL136937A0 (en) | τ-GLUTAMYL AND β-ASPARTYL CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| GB2311940B (en) | Pharmaceutical compositions for the treatment of rhinitis | |
| AU2466695A (en) | The use of famotidine and related compounds in the treatment of movement disorders | |
| IL128058A0 (en) | Illudin analogs and pharmaceutical compositions containing the same | |
| ZA954984B (en) | Compositions and methods for the treatment of tumors | |
| AU7384094A (en) | Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders | |
| IL125284A0 (en) | Cephem compounds pharmaceutical compositions containing the same and use thereof | |
| AU2557895A (en) | Composition for treating gastrointestinal disorders | |
| AU5446798A (en) | Compositions and methods for the treatment of gastrointestinal disorders | |
| AU6720698A (en) | Pharmaceutical compositions containing colostrum and the use of colostrum for the treatment of hair loss | |
| GB9415901D0 (en) | Novel compounds and treatment | |
| GB9726223D0 (en) | The treatment of materials | |
| GB9415900D0 (en) | Novel compounds and treatment | |
| AU5733596A (en) | Compositions containing bismuth, for the treatment and preve ntion of gastrointestinal disorders | |
| ZA951226B (en) | The treatment of gaseous substances | |
| IL125371A0 (en) | 3-Methylimidazopyridine compounds pharmaceutical compositions containing the same and use thereof |